Clinical Trials Sponsored by Fervent Pharmaceuticals
Total 19814 results
-
Ferring PharmaceuticalsCompletedControlled Ovarian StimulationDenmark, Norway, Sweden, Switzerland
-
Theseus PharmaceuticalsTerminatedGastrointestinal Diseases | Neoplasms | Neoplasms, Connective and Soft Tissue | Neoplasms by Histologic Type | Gastrointestinal Neoplasms | Neoplasms, Connective Tissue | Digestive System Neoplasm | Digestive System Disease | Gastrointestinal Stromal Tumors (GIST)United States
-
Azurity PharmaceuticalsCompletedAbuse PotentialUnited States
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisUnited States
-
Vanda PharmaceuticalsActive, not recruitingNon 24 Hour Sleep Wake DisorderFrance
-
Regeneron PharmaceuticalsActive, not recruitingHealthy VolunteersBelgium
-
Regeneron PharmaceuticalsActive, not recruiting
-
Alnylam PharmaceuticalsTerminated
-
Vanda PharmaceuticalsCompletedAutism Spectrum Disorder | Smith-Magenis Syndrome | Non-24 Hour Sleep-Wake Disorder | Circadian Rhythm Sleep DisordersUnited States
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis | Amyloidosis, HereditaryUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Cyprus, France, Germany, Greece, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Taiwan, United Kingdom
-
BioCryst PharmaceuticalsActive, not recruitingHereditary Angioedema | PediatricSpain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
-
CStone PharmaceuticalsCompletedRelapsed Small Cell Lung CancerChina
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Longboard PharmaceuticalsAvailableDravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic EncephalopathiesUnited States
-
BioCryst PharmaceuticalsTerminatedBCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy (REDEEM-1)Paroxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, Hungary, France, Italy, Spain
-
Alnylam PharmaceuticalsNo longer availableTransthyretin-mediated Amyloidosis With Cardiomyopathy | ATTR Amyloidosis With CardiomyopathyUnited States
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Alnylam PharmaceuticalsApproved for marketingPrimary HyperoxaluriaBelgium
-
Botanix PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompletedInfertility, FemaleUnited States
-
Endo PharmaceuticalsCompletedProstate Cancer | Adenocarcinoma of the Prostate
-
Endo PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedCarpal Tunnel Syndrome | Complex Regional Pain Syndrome | Peripheral Neuropathy | Diabetic Neuropathy | Postherpetic Neuralgia | HIV Neuropathy | Idiopathic Sensory NeuropathyUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
Regeneron PharmaceuticalsCompleted
-
Response PharmaceuticalsCompletedDrug-induced Weight GainUnited States
-
Lexicon PharmaceuticalsCompletedPostherpetic NeuralgiaUnited States, Czechia, Poland
-
Response PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Ferring PharmaceuticalsCompletedCrohn's DiseaseUnited States, Netherlands, Israel, Germany
-
Santhera PharmaceuticalsAvailableDuchenne Muscular DystrophyUnited States, Canada, Israel
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
ERX PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsAvailableParoxysmal Nocturnal Hemoglobinuria (PNH) | CD55-deficient Protein-losing Enteropathy (PLE) | CD59 Deficiency
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
eXIthera PharmaceuticalsWithdrawnCovid19 | ThrombopeniaUnited States
-
Vanda PharmaceuticalsAvailableGastroparesis | Diabetic GastroparesisUnited States
-
Impel PharmaceuticalsTerminatedAgitation in Adolescents and Young Adults With ASDUnited States
-
Ferring PharmaceuticalsCompletedPostpartum HemorrhageUnited States
-
Vanda PharmaceuticalsCompletedJet Lag Type InsomniaUnited States
-
Dizal PharmaceuticalsActive, not recruitingBreast Cancer MetastaticChina, United States
-
Endo PharmaceuticalsCompletedCellulite | Edematous Fibrosclerotic PanniculopathyUnited States
-
X4 PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedEdematous SkinUnited States
-
Inovio PharmaceuticalsCompletedHuman Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the VulvaUnited States
-
Ferring PharmaceuticalsCompletedControlled Ovarian SimulationKorea, Republic of, Taiwan, China, Vietnam
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Ferring PharmaceuticalsCompletedEndometriosis-related PainUnited States